19-40397633-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_181882.3(PRX):​c.719G>A​(p.Arg240Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000255 in 1,543,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R240W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

PRX
NM_181882.3 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.244

Publications

0 publications found
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]
PRX Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 4F
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • Charcot-Marie-Tooth disease type 3
    Inheritance: AD, AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057433546).
BP6
Variant 19-40397633-C-T is Benign according to our data. Variant chr19-40397633-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 476979.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00126 (192/152318) while in subpopulation AFR AF = 0.00442 (184/41590). AF 95% confidence interval is 0.0039. There are 0 homozygotes in GnomAd4. There are 96 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181882.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRX
NM_181882.3
MANE Select
c.719G>Ap.Arg240Gln
missense
Exon 7 of 7NP_870998.2
PRX
NM_001411127.1
c.1004G>Ap.Arg335Gln
missense
Exon 7 of 7NP_001398056.1
PRX
NM_020956.2
c.*924G>A
3_prime_UTR
Exon 6 of 6NP_066007.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRX
ENST00000324001.8
TSL:1 MANE Select
c.719G>Ap.Arg240Gln
missense
Exon 7 of 7ENSP00000326018.6
PRX
ENST00000291825.11
TSL:1
c.*924G>A
3_prime_UTR
Exon 6 of 6ENSP00000291825.6
PRX
ENST00000674005.2
c.1004G>Ap.Arg335Gln
missense
Exon 7 of 7ENSP00000501261.1

Frequencies

GnomAD3 genomes
AF:
0.00126
AC:
192
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00444
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000314
AC:
44
AN:
140038
AF XY:
0.000221
show subpopulations
Gnomad AFR exome
AF:
0.00486
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000240
GnomAD4 exome
AF:
0.000145
AC:
201
AN:
1390822
Hom.:
0
Cov.:
35
AF XY:
0.000132
AC XY:
91
AN XY:
686936
show subpopulations
African (AFR)
AF:
0.00474
AC:
152
AN:
32034
American (AMR)
AF:
0.0000831
AC:
3
AN:
36094
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25176
East Asian (EAS)
AF:
0.0000275
AC:
1
AN:
36416
South Asian (SAS)
AF:
0.000327
AC:
26
AN:
79576
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5204
European-Non Finnish (NFE)
AF:
0.00000555
AC:
6
AN:
1081856
Other (OTH)
AF:
0.000224
AC:
13
AN:
58046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00126
AC:
192
AN:
152318
Hom.:
0
Cov.:
33
AF XY:
0.00129
AC XY:
96
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00442
AC:
184
AN:
41590
American (AMR)
AF:
0.000196
AC:
3
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68006
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000467
Hom.:
0
Bravo
AF:
0.00150
ESP6500AA
AF:
0.00339
AC:
12
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000317
AC:
35
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 4F Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

not specified Benign:1
May 07, 2024
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Sep 19, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:1
Apr 09, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Charcot-Marie-Tooth disease type 4 Benign:1
Oct 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.24
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.61
N
REVEL
Benign
0.031
Sift
Benign
0.10
T
Sift4G
Benign
0.53
T
Polyphen
0.086
B
Vest4
0.11
MVP
0.25
MPC
0.48
ClinPred
0.010
T
GERP RS
-0.14
Varity_R
0.049
gMVP
0.27
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77917609; hg19: chr19-40903540; API